axoCells™ human iPSC-derived motor neurons (unaffected), male donor, aged 74, ≥2 million cells

axoCells vials

>>> READY TO SHIP PRODUCT

This product has been discontinued. We recommend using our axoCellsTM motor neurons (ax0076) and the kit (ax0186).

  • Derived from human iPSCs
  • Assay-ready in just 10 days
  • Expression of the key markers including HB9, MAP2, LIM3 and ChAT2
  • Designed for advanced in vitro model formats including co-culture and organ-on-chip platforms
  • RNAseq and TempO-Seq™ data available on request
Price:

SKU: ax0078
Specifications

Number of cells ≥2 million cells
Donor Male, 74-year-old
Genetics Healthy control

Description

axoCells Human iPSC-Derived Motor Neurons (≥2 million cells) for neuroscience research. Motor neurons made from iPSCs generated from a 74-year-old male donor’s pulmonary fibroblasts.

Key highlights include:
• Assay-ready in just 10 days
• Expression of the key markers including HB9, MAP2, LIM3 and ChAT2
• Designed for advanced in vitro model formats including co-culture and organ-on-chip platforms
• Manufactured in our ISO 9001-accredited production facility with excellent ISSCR Standards compliance

With our axoCells iPSC-derived motor neurons, you can unlock the benefits of iPSC technology for your in vitro neuromuscular disease models.

Please note: The ethical guidelines for the source material used to generate cell line ax7018 do not provide legal consent for, nor permit, sequencing of any derived cells or materials, including the following products: ax0018, ax0078, ax2508, ax2558, ax2518, ax2568, and ax3078.

Top Resources

No results found.
Additional Information

Phenotypic characterization: morphology

axoCells motor neurons demonstrate expected physiological morphology with uniform cell clusters and large cabling neuronal networks.

axoCells motor neurons demonstrate expected physiological morphology with uniform cell clusters and large cabling neuronal networks.

Phase contrast images of axoCells motor neurons matured from progenitors over 21 days.

Phenotypic characterization: ICC

axoCells motor neurons express key markers (TUJ1, ChAT) demonstrating phenotypic relevance.

Immunocytochemistry of day 21 mature axoCells motor neurons demonstrating presence of key markers (ChAT and TUJ1). Images captured on a Leica microscope x20 magnification. Error bar= 200um

Immunocytochemistry of day 21 mature axoCells motor neurons demonstrating presence of key markers (ChAT and TUJ1). Images captured on a Leica microscope x20 magnification. Error bar= 200um

Functional relevance: MEA

axoCells motor neurons exhibit synchronized burst firing, demonstrating their functional relevance

axoCells motor neurons exhibit synchronized burst firing, demonstrating their functional relevance

axoCells motor neuron firing assessed at day 10 using the Axion Maestro Pro multi-electrode array (MEA) system. Here you can see sodium spike firing and network burst firing responses of the motor neurons.

Left: sodium spike profile, right: Raster plot showing burst firing events (blue boxes) with synchronized firing highlighted in pink boxes.

Functional relevance: SNA (spontaneous neural activity)

axoCells motor neurons exhibit regular, synchronized firing on calcium imaging, demonstrating their functional relevance.

axoCells motor neurons exhibit regular, synchronized firing on calcium imaging, demonstrating their functional relevance.

Firing pattern of axoCells motor neurons at day 21, transfected with NeuroBurst (calcium-sensitive lentivirus driven off the synapsin reporter) to pick up spontaneous neuronal activity on an IncuCyte. This demonstrates regular, synchronized firing with a mean correlation of 0.92. Potential parameters measured include mean correlation, burst rate, burst duration and burst strength.

Disease line vs control: ALS phase contrast

ALS-derived motor neurons form smaller, less uniform bodies with thinner neurite extensions compared to healthy axoCells motor neurons.

ALS-derived motor neurons form smaller, less uniform bodies with thinner neurite extensions compared to healthy axoCells motor neurons.

Phase contrast images of mature axoCells motor neurons (day 21) from healthy (left, ax0078) and ALS (right, ax0074) background.

Disease line vs control: ALS ICC

Compared to healthy axoCells motor neurons, ALS neurons form smaller, less uniform bundles, with thinner neurites. Healthy axoCells motor neurons form large, thick cabling between uniformly clustered bundles.

Compared to healthy axoCells motor neurons, ALS neurons form smaller, less uniform bundles, with thinner neurites. Healthy axoCells motor neurons form large, thick cabling between uniformly clustered bundles.

Immunocytochemistry of healthy control-derived axoCells motor neurons (top) and ALS-derived axoCells motor neurons (bottom) at day 21. Composite image for each channel and merged. Image captured on a Leica microscope at x20 magnification

Disease line vs control: SNA

Compared to healthy axoCells motor neurons, ALS-derived motor neurons exhibit less frequent and less-synchronized firing.

Healthy motor neurons show regular synchronous firing compared to ALS which fire more frequently, for shorter duration and in a less-synchronized manner.

axoCells healthy control and ALS-derived motor neurons were matured for 21 days and transfected with Neuroburst Orange to look at spontaneous neuronal activity on the IncuCyte S3. Healthy motor neurons show regular synchronous firing compared to ALS which fire more frequently, for shorter duration and in a less-synchronized manner (shown by burst duration and rate). N=3, ***p<0.001, ****p<0.0001

axoModels: neuromuscular junction (NMJ)

Here is an example of a complex model we have built with motor neurons. As part of our axoModels offering, we are collaborating with biopharma organizations to build complex in vitro models, including an NMJ.

axoCells motor neurons matured on a microfluidics device with skeletal muscle in the opposite chamber.

axoCells motor neurons matured on a microfluidics device with skeletal muscle in the opposite chamber. Neurite extensions can be observed passing through the grooves and innervating the skeletal muscle to form functional neuromuscular junctions (shown by bungarotoxin staining). A 3D model (not shown) has also been developed using a scaffold for the motor neurons, which are placed on top of skeletal muscle.

Applications

Our axoCellsTM motor neurons have been specifically developed for use in in vitro disease modeling and drug discovery. As a neuromuscular junction (NMJ) model with iPSC derived skeletal muscle, our ALS, unaffected ALS and healthy motor neurons have been used in both 2D and 3D formats to characterize and measure structural and functional phenotypic responses in vitro.   

We have a community of top ten biopharma and research institutes that use our motor neurons to build powerful in vitro models, investigating neurodegenerative disorders such as ALS and for drug screening

Protocols

 A fully validated protocol for accelerated maturation of motor neurons is available here.

Quality

We maintain or exceed industry-level quality with our ISO:9001-accredited production facility, guided by our rigorous quality control procedures and decades of scientific experience.  

All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

Licenses & Consent

Axol has obtained all relevant licenses for reprogramming donor samples into iPSCs and differentiating these into motor neurons for commercial use.  

Patient samples used to create these neurons have been ethically sourced and consented for research and commercial use. All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

McCallister TX et al. A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD. bioRxiv (2023) [Preprint]. doi: 10.1101/2023.12.12.571328.

Spijkers, X.M., Pasteuning-Vuhman, S., Dorleijn, J.C. et al. A directional 3D neurite outgrowth model for studying motor axon biology and disease. Sci Rep 11, 2080 (2021). https://doi.org/10.1038/s41598-021-81335-z

Fiskum Vegard, Sandvig Axel, Sandvig Ioanna 2021. Silencing of Activity During Hypoxia Improves Functional Outcomes in Motor Neuron Networks in vitro. Frontiers in Integrative Neuroscience 15 2021.  DOI=10.3389/fnint.2021.792863    

Rimington, R.P., Fleming, J.W., Capel, A.J. et al. Bioengineered model of the human motor unit with physiologically functional neuromuscular junctions. Sci Rep 11, 11695 (2021). https://doi.org/10.1038/s41598-021-91203-5

Media and Reagents

An optimized media and all growth factors are available to mature motor neurons in culture within 10 days of thaw.